Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 10, 2011, Pages 2347-2355

  Heller, Frank ^a   Frischmann, Sandra ^a   Grünbaum, Maria ^a   Zidek, Walter ^a   Westhoff, Timm H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CREATININE; SODIUM;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CALPROTECTIN URINE LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRINSIC ACUTE KIDNEY INJURY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRERENAL ACUTE KIDNEY INJURY; PROTEIN URINE LEVEL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SODIUM URINE LEVEL; URINARY TRACT INFECTION;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; CREATININE; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 80053911499     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02490311     Document Type: Article

References (20)

1. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ: Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135-1142, 2006
2. Schrier RW: Need to intervene in established acute renal failure. J Am Soc Nephrol 15: 2756-2758, 2004
3. Steiner RW: Interpreting the fractional excretion of sodium. Am J Med 77: 699-702, 1984
4. Pepin MN, Bouchard J, Legault L, Ethier J: Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment. Am J Kidney Dis 50: 566-573, 2007
5. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31, 2007
6. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Mac- Donald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229, 1984
7. Bjerke K, Halstensen TS, Jahnsen F, Pulford K, Brandtzaeg P: Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 34: 1357-1363, 1993
8. Pillay SN, Asplin JR, Coe FL: Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol 275: F255-F261, 1998
9. Thurgood LA, Ryall RL: Proteomic analysis of proteins selectively associated with hydroxyapatite, brushite, and uric acid crystals precipitated from human urine. J Proteome Res 9: 5402-5412
10. Poullis A, Foster R, Northfield TC, Mendall MA: Review article: Faecal markers in the assessment of activity in inflammatory bowel disease. Aliment Pharmacol Ther 16: 675-681, 2002
11. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J: Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049, 2007
12. Foell D, Wittkowski H, Roth J: Monitoring disease activity by stool analyses: From occult blood to molecular markers of intestinal inflammation and damage. Gut 58: 859-868, 2009
13. Gisbert JP, McNicholl AG: Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis 41: 56-66, 2009
14. Giorgini A, Brown HJ, Sacks SH, Robson MG: Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells. Am J Pathol 177: 644-653
15. Soylu A, Kizildag S, Kavukcu S, Cingoz S, Turkmen M, Demir BK, Sakizli M: TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch-Schonlein purpura with and without renal involvement. Rheumatol Int 30: 667-670
16. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J: The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 6: 224-235
17. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van't Veer C: In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFNgamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168: 1286-1293, 2002
18. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I: Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123: 450-460, 2002
19. Lundberg JO, Hellstrom PM, Fagerhol MK, Weitzberg E, Roseth AG: Technology insight: Calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2: 96-102, 2005
20. Angriman I, Scarpa M, D'Inca R, Basso D, Ruffolo C, Polese L, Sturniolo GC, D'Amico DF, Plebani M: Enzymes in feces: Useful markers of chronic inflammatory bowel disease. Clin Chim Acta 381: 63-68, 2007